BSE filing, NSE: SSORGS. Summary written from the filing by ALFA Finder's alert engine.
Oxygenta Pharmaceutical Ltd: key numbers
- Share price
- ₹47.96
- Market cap
- ₹177.4 Cr
- Revenue (annual)
- ₹113.0 Cr
- Net profit (annual)
- ₹-17.57 Cr
- P/E (TTM)
- -13.1×Sector 46.1×
- Promoter holding
- 56.54%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Oxygenta Pharmaceutical Ltd
All →Oxygenta Pharmaceutical Acquisition Worth ₹6.75 Cr
Oxygenta Pharmaceutical acquired land in Telangana from TGIIC for Rs. 6.75 Crore. The purchase supports business expansion and long-term strategic infrastructure needs.
- Value
- ₹6.75 Cr
Oxygenta Pharmaceutical Annual General Meeting
Oxygenta Pharmaceutical Limited conducted its 33rd Annual General Meeting on August 21, 2026, via video conferencing to discuss and adopt various corporate business resolutions.
Oxygenta Pharmaceutical Annual Report
Oxygenta Pharmaceutical has submitted its 33rd Annual Report for FY 2025-26, including the notice for the upcoming Annual General Meeting scheduled for August 21, 2026.
Oxygenta Pharmaceutical Annual General Meeting
Oxygenta Pharmaceutical Limited announced its 33rd Annual General Meeting scheduled for August 21, 2026. The notice includes director appointments and adoption of the company's financial statements.
Oxygenta Pharmaceutical Other Announcement
Oxygenta Pharmaceutical Limited has appointed M/s. PCR & Associates as its Cost Auditor for a 12-month term. This appointment follows the company's recent board meeting.
Oxygenta Pharmaceutical Q1 FY27 Results: Net Loss of ₹2.1 Cr, Loss Narrows
Oxygenta Pharmaceutical Ltd reported revenue from operations of ₹37 Cr (+145.0% YoY) and a net loss of ₹2.1 Cr for Q1 FY27.
- Key figure
- Net loss ₹2.1 Cr
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.